Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

20 Jul 2012 11:06

RNS Number : 1557I
Maven Income & Growth VCT PLC
20 July 2012
 



Interim Management Statement

 

Maven Income and Growth VCT PLC (the Company) - quarter ended 31 May 2012

 

This Interim Management Statement, for the quarter ended 31 May 2012, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 June 2012 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

·; Net Asset Value (NAV)1 of 72.3p per share at 31 May 2012, compared to 67.9p per share at 29 February 2012;

·; NAV total return2 of 116.4p at 31 May 2012, compared to 112.0p at 29 February 2012; and

·; Final dividend of 3.5p per share in respect of the year ending 29 February 2012 to be paid on 20 July 2012.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 31 May 2012. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 29 February 2012, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 31 May 2012, five unlisted investments were completed, including the provision of support to one existing portfolio company, and a total of £2,035,000 was invested. During the same period, the full or partial disposal of eight unlisted holdings realised proceeds of £1,732,000 against cost of £1,504,000.

 

3.

Recent developments

 

As announced on 6 June 2012, the Company completed the disposal of its investment in TPL (Midlands) Limited (trading as Transys Projects Limited) on 1 June 2012. For contractual reasons, the Directors were not able to publish specific details of the transaction. However, the unaudited NAV of the Company increased by approximately 4.7p as a direct result of this disposal and this has also been reflected in the calculation of the NAV as at 31 May 2012.

 

Between 1 June 2012 and the date of this Statement, the Company also sold its investment in Nessco Group Holdings, realising proceeds of £1,551,000 against an invested cost of £710,000 and the valuation of £1,236,000 as at 31 May 2012. In the same period, the Company also provided total additional funding of £560,000 in support of three existing portfolio companies; sold an AIM quoted holding to realise proceeds of £2,000 against a cost of £3,000; and made a net investment of £4,013,000 in UK government securities.

 

Other than as described above and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 March 2012 to 31 May 2012, or in the period from 1 June 2012 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

20 July 2012

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSPGUAUMUPPGUU
Date   Source Headline
28th Jan 202511:25 amRNSDirector/PDMR Shareholding
28th Jan 202510:39 amRNSIssue of Equity
24th Jan 202511:32 amRNSNet Asset Value(s)
29th Nov 20249:33 amRNSIssue of Equity - Dividend Investment Scheme
26th Nov 20243:51 pmRNSStatement re Dividend Investment Scheme
14th Nov 20242:51 pmRNSResult of General Meeting
24th Oct 20247:00 amRNSHalf-year Report
17th Oct 20244:27 pmRNSTransaction in Own Shares
16th Oct 20244:59 pmRNSTransaction in Own Shares
14th Oct 20243:25 pmRNSUnaudited Net Asset Value and Interim Dividend
27th Sep 20244:31 pmRNSPublication of a Prospectus
5th Sep 20244:45 pmRNSUnaudited Net Asset Value
19th Jul 20242:25 pmRNSIssue of Equity - Dividend Investment Scheme
18th Jul 20244:16 pmRNSTransaction in Own Shares
17th Jul 20245:03 pmRNSTransaction in Own Shares
15th Jul 20243:07 pmRNSStatement re Dividend Investment Scheme
15th Jul 20242:23 pmRNSStatement re Dividend Investment Scheme
12th Jul 20242:56 pmRNSNet Asset Value(s)
11th Jul 20241:38 pmRNSResult of AGM
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
31st May 20244:16 pmRNSFinal Results
16th May 20243:13 pmRNSTransaction in Own Shares
1st May 202410:02 amRNSIssue of Equity
26th Apr 20241:33 pmRNSUnaudited NAV & Proposed Final Dividend
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:47 pmRNSIssue of Equity
27th Mar 202410:34 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
21st Mar 20243:55 pmRNSStatement re Offer for Subscription
20th Mar 20243:44 pmRNSUnaudited Net Asset Value
8th Feb 202410:27 amRNSDirector/PDMR Shareholding
8th Feb 202410:26 amRNSDirector/PDMR Shareholding
8th Feb 202410:08 amRNSIssue of Equity
30th Jan 20245:09 pmRNSTransaction in Own Shares
17th Jan 20249:59 amRNSDirector/PDMR Shareholding
17th Jan 20249:57 amRNSIssue of Equity
15th Jan 20244:25 pmRNSUnaudited Net Value Asset
1st Dec 20239:39 amRNSIssue of Equity
24th Nov 202312:04 pmRNSStatement re Dividend Investment Scheme
9th Nov 20233:35 pmRNSResult of General Meeting
19th Oct 20234:51 pmRNSTransaction in Own Shares
18th Oct 20233:54 pmRNSHalf-year Report
13th Oct 20234:56 pmRNSPublication of a Prospectus
5th Oct 20234:39 pmRNSNet Asset Value and Interim Dividend
20th Jul 20234:32 pmRNSTransaction in Own Shares
14th Jul 20239:26 amRNSIssue of Equity
7th Jul 20234:17 pmRNSStatement re Dividend Investment Scheme
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value
6th Jul 20231:06 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.